Actuate Therapeutics, Inc. (ACTU)

Actuate Therapeutics Statistics

Total Valuation

ACTU has a market cap or net worth of $137.37 million. The enterprise value is $120.44 million.

Market Cap	137.37M
Enterprise Value	120.44M

Important Dates

The last earnings date was Thursday, November 13, 2025, after market close.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

ACTU has 23.24 million shares outstanding. The number of shares has increased by 418.68% in one year.

Current Share Class	23.24M
Shares Outstanding	23.24M
Shares Change (YoY)	+418.68%
Shares Change (QoQ)	+8.90%
Owned by Insiders (%)	4.12%
Owned by Institutions (%)	5.92%
Float	9.60M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	12.56
P/TBV Ratio	12.56
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.74

Current Ratio	2.74
Quick Ratio	2.66
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1,202.43

Financial Efficiency

Return on equity (ROE) is -296.04% and return on invested capital (ROIC) is -186.91%.

Return on Equity (ROE)	-296.04%
Return on Assets (ROA)	-95.25%
Return on Invested Capital (ROIC)	-186.91%
Return on Capital Employed (ROCE)	-214.84%
Revenue Per Employee	n/a
Profits Per Employee	-$2.41M
Employee Count	10
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -30.96% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-30.96%
50-Day Moving Average	6.97
200-Day Moving Average	7.74
Relative Strength Index (RSI)	35.12
Average Volume (20 Days)	36,936

Short Selling Information

The latest short interest is 491,311, so 2.11% of the outstanding shares have been sold short.

Short Interest	491,311
Short Previous Month	561,356
Short % of Shares Out	2.11%
Short % of Float	5.12%
Short Ratio (days to cover)	7.32

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-24.37M
Pretax Income	-24.12M
Net Income	-24.12M
EBITDA	n/a
EBIT	-24.37M
Earnings Per Share (EPS)	-$1.20

Balance Sheet

The company has $16.92 million in cash and n/a in debt, giving a net cash position of $16.92 million or $0.73 per share.

Cash & Cash Equivalents	16.92M
Total Debt	n/a
Net Cash	16.92M
Net Cash Per Share	$0.73
Equity (Book Value)	10.94M
Book Value Per Share	0.47
Working Capital	11.07M

Cash Flow

Operating Cash Flow	-20.24M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ACTU does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-418.68%
Shareholder Yield	-418.68%
Earnings Yield	-17.56%
FCF Yield	n/a

Analyst Forecast

The average price target for ACTU is $20.00, which is 238.41% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$20.00
Price Target Difference	238.41%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2